Portal de Periódicos da CAPES

Fluoxetine in the Long-Term Maintenance Treatment of Obsessive Compulsive Disorder

1989; Slack Incorporated (United States); Volume: 19; Issue: 2 Linguagem: Inglês

10.3928/0048-5713-19890201-09

1938-2456

Réjean Fontaine, Guy Chouinard,

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Obsessive Compulsive DisorderFluoxetine in the Long-Term Maintenance Treatment of Obsessive Compulsive Disorder Rejean Fontaine, MD, , and , MD Guy Chouinard, MD, , MD Rejean Fontaine, MD and Guy Chouinard, MD Psychiatric Annals, 2013;19(2):88–91Published Online:February 01, 1989https://doi.org/10.3928/0048-5713-19890201-09Cited by:40View Full TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Fabre LF, Crismon ML: Efficacy of fluoxetine in outpatients with major depression. Current Therapeutic Research 1985; 37:115-123. > Google Scholar2. Rickels K, Amsterdam JD, Avallone MF: Fluoxetine in major depression: A controlled study. Current Therapeutic Research 1986; 39:559-563. > Google Scholar3. Stark P. Hardison CD: A review of multicenter controlled studies of fluoxetine vs Imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 1985; 46:53-58. > Google Scholar4. Cohn JB, Wilcox C: A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder. J Clin Psychiatry 1985; 46:26-31. > Google Scholar5. Chouinard G: A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. J Clin Psychiatry 1985: 46:32-37. > Google Scholar6. Turner SM, Jacob RG, Beidel DC, et al: Fluoxetine treatment of obsessive compulsive disorder. J Clin Psychophannacoi 1985; 5:201-212. > Google Scholar7. Fontaine R, Chouinard G: Fluoxetine in the treatment of obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 1985; 9:605-608. > Google Scholar8. Rickels K, Smith WT, Vincent G1 et al: Comparison of two dosage regimens of fluoxetine in major depression. J Clin Psychiatry 1985;46:38-41. > Google Scholar9. Wernicke iF: The side effect profile and safety of fluoxetine. J Clin Psychiatry 1985; 46:59-67. > Google Scholar10. Sommi RW, Crismon ML, Bowden CL: Fluoxetine: A serotonin-specific, secondgeneration antidepressant. Pharmacotherapy 1987; 7:1-15. > Google Scholar11. Hall H, Sallemark M, Wedel 1: Acute effects of atypical antidepressants on various receptors in the rat brain. Acta Pharmacologica and Toxicology 1984; 54:379-384. > Google Scholar12. Fuller RW. Snoddy HD. Perry KW, et al: Importance of duration of drug action in the antagonism of p=chloramphetamine depletion of brain serotonin - Comparison of fluoxetine and clomipramine. Biochem Pharmacol 1978; 27:193-198. > Google Scholar13. Wong DT. Bymaster FP. Reid LR, et al: Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors. Biochem Pharmacol 1983; 32:1287-1293. > Google Scholar14. Hyttel J, Larsen JJ: Serotonin-selective antidepressants. Acta Pharmacol Toxicol 1985; 56:146-153. > Google Scholar15. Byerley WF, McConnell EJ. McCabe RT, et al: Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine. Psvchopharmacology 1988;94:141-143. > Google Scholar16. Zohar J, Insel TR: Obsessive-compulsive disorder: Psychobiologieal approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry 1987; 22:667-687. > Google Scholar17. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology. rev. Rockville, Md, National Institute of Mental Health, Psychopharmacology Research Branch, 1976. > Google Scholar18. Asberg M, Montgomery SA, Perris C, et al: A comprehensive psychopathological rating scale. Acta Psychiatr Scand 1978; 271:5-27. > Google Scholar19. Allen JJ, Tune GS: The Lynfield Obsessional/Compulsive Questionnaires. Scott Med J 1975; 20:21-29. > Google Scholar20. Pato M, Zohar J, lnsel TR: Return of symptoms after discontinuation of clomipramine. Presented at the 141st Annual Meeting of the American Psychiatric Association, Montreal. May 7-12. 1988 (No 93C of the Proceedings of the American Psychiatric Association Meetings). > Google Scholar21 . Fontaine R, Chouinard G. Iny L: An open clinical trial of zimelidine in the treatment of obsessive compulsive disorder. Current Therapeutic Research 1985; 37:326-332. > Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Shannahoff-Khalsa D (2004) An Introduction to Kundalini Yoga Meditation Techniques That Are Specific for the Treatment of Psychiatric Disorders, The Journal of Alternative and Complementary Medicine, 10.1089/107555304322849011, 10:1, (91-101), Online publication date: 1-Feb-2004. Jenike M (2004) Obsessive–Compulsive Disorder, New England Journal of Medicine, 10.1056/NEJMcp031002, 350:3, (259-265), Online publication date: 15-Jan-2004. Simpson H, Liebowitz M, Foa E, Kozak M, Schmidt A, Rowan V, Petkova E, Kjernisted K, Huppert J, Franklin M, Davies S and Campeas R (2004) Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder, Depression and Anxiety, 10.1002/da.20003, 19:4, (225-233), . Bian J, Yeh J, Aistrup G, Narahashi T and Moore E (2002) Inhibition of K+ currents of outer hair cells in guinea pig cochlea by fluoxetine, European Journal of Pharmacology, 10.1016/S0014-2999(02)02421-4, 453:2-3, (159-166), Online publication date: 1-Oct-2002. Romano S, Goodman W, Tamura R and Gonzales J (2001) Long-Term Treatment of Obsessive-Compulsive Disorder After an Acute Response: A Comparison of Fluoxetine Versus Placebo, Journal of Clinical Psychopharmacology, 10.1097/00004714-200102000-00009, 21:1, (46-52), Online publication date: 1-Feb-2001. Maina G, Albert U and Bogetto F (2001) Relapses after discontinuation of drug associated with increased resistance to treatment in obsessive-compulsive disorder, International Clinical Psychopharmacology, 10.1097/00004850-200101000-00004, 16:1, (33-38), Online publication date: 1-Jan-2001. Shannahoff-Khalsa D, Ray L, Levine S, Gallen C, Schwartz B and Sidorowich J (2014) Randomized Controlled Trial of Yogic Meditation Techniques for Patients With Obsessive-Compulsive Disorder, CNS Spectrums, 10.1017/S1092852900006805, 4:12, (34-47), Online publication date: 1-Dec-1999. FRANKLIN M, KOZAK M, CASHMAN L, COLES M, RHEINGOLD A and FOA E (1998) Cognitive‐Behavioral Treatment of Pediatric Obsessive‐Compulsive Disorder: An Open Clinical Trial, Journal of the American Academy of Child & Adolescent Psychiatry, 10.1097/00004583-199804000-00019, 37:4, (412-419), Online publication date: 1-Apr-1998. Steketee G and Frost R (1998) Obsessive-compulsive Disorder Comprehensive Clinical Psychology, 10.1016/B0080-4270(73)00199-1, (367-398), . Dolberg O, Iancu I and Zohar J (2020) Duración del tratamiento del trastorno obsesivo compulsivo, European psychiatry (Ed. Española), 10.1017/S1134066500001454, 4:5, (293-297), Online publication date: 1-Jul-1997. Mundo E, Bareggi S, Pirola R, Bellodi L and Smeraldi E (1997) Long-Term Pharmacotherapy of Obsessive-Compulsive Disorder, Journal of Clinical Psychopharmacology, 10.1097/00004714-199702000-00002, 17:1, (4-10), Online publication date: 1-Feb-1997. A. PIGOTT T and SEAY S (2009) Pharmacotherapy of obsessive-compulsive disorder, International Review of Psychiatry, 10.1080/09540269775655, 9:1, (133-148), Online publication date: 1-Jan-1997. Chouinard G, Belanger M, Beauclair L, Sultan S and Murphy B (1996) Potentiation of fluoxetine by aminoglutethimide, an adrenal steroid suppressant. in obsessive-compulsive disorder resistant to ssris: A case report, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/0278-5846(96)00084-X, 20:6, (1067-1079), Online publication date: 1-Aug-1996. Shannahoff-khalsa D and Beckett L (2009) Clinical Case Report: Efficacy of Yogic Techniques in the Treatment of Obsessive Compulsive D Isorders, International Journal of Neuroscience, 10.3109/00207459608986347, 85:1-2, (1-17), Online publication date: 1-Jan-1996. Dolberg O, lancu I and Zohar J (1996) Treatment duration of obsessive compulsive disorder, European Psychiatry, 10.1016/S0924-9338(97)82578-3, 11:8, (403-406), Online publication date: 1-Jan-1996. Kozak M and Foa E (1996) Obsessive—Compulsive Disorder Sourcebook of Psychological Treatment Manuals for Adult Disorders, 10.1007/978-1-4899-1528-3_3, (65-122), . Wong D, Bymaster F and Engleman E (1995) Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication, Life Sciences, 10.1016/0024-3205(95)00209-O, 57:5, (411-441), Online publication date: 1-Jun-1995. Chappell P, Leckman J and Riddle M (1995) The Pharmacologic Treatment of Tic Disorders, Child and Adolescent Psychiatric Clinics of North America, 10.1016/S1056-4993(18)30457-7, 4:1, (197-216), Online publication date: 1-Jan-1995. Lipinski J and Pope H (1994) Do "flashbacks" represent obsessional imagery?, Comprehensive Psychiatry, 10.1016/0010-440X(94)90014-0, 35:4, (245-247), Online publication date: 1-Jul-1994. DeVeaugh-Geiss J (1994) Pharmacologic Therapy of Obsessive Compulsive Disorder , 10.1016/S1054-3589(08)60171-4, (35-52), . Fishbain D, Trescott J, Cutler B, Abdel-Moty E, Rosomoff R and Rosomoff H (1993) Do Some Chronic Pain Patients With Atypical Facial Pain Overvalue and Obsess About Their Pain?, Psychosomatics, 10.1016/S0033-3182(93)71870-8, 34:4, (355-359), Online publication date: 1-Jul-1993. Cox B, Swinson R, Morrison B and Lee P (1993) Clomipramine, flouxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: A meta-analysis, Journal of Behavior Therapy and Experimental Psychiatry, 10.1016/0005-7916(93)90043-V, 24:2, (149-153), Online publication date: 1-Jun-1993. Sturgis E (1993) Obsessive-Compulsive Disorders Comprehensive Handbook of Psychopathology, 10.1007/978-1-4615-3008-4_7, (129-144), . Jenike M (1992) Pharmacologic Treatment of Obsessive Compulsive Disorders *, Psychiatric Clinics of North America, 10.1016/S0193-953X(18)30217-X, 15:4, (895-919), Online publication date: 1-Dec-1992. Piacentini J, Jaffer M, Gitow A, Graae F, Davies S, Bene D and Liebowitz M (1992) Psychopharmacologic Treatment of Child and Adolescent Obsessive Compulsive Disorder, Psychiatric Clinics of North America, 10.1016/S0193-953X(18)30259-4, 15:1, (87-107), Online publication date: 1-Mar-1992. Casey D (2016) Obsessive-compulsive disorder, Postgraduate Medicine, 10.1080/00325481.1992.11701203, 91:2, (171-174), Online publication date: 1-Feb-1992. Bakish D (1991) Fluoxetine Potentiation by Buspirone: Three Case Histories, The Canadian Journal of Psychiatry, 10.1177/070674379103601012, 36:10, (749-750), Online publication date: 1-Dec-1991. Alarcon R (2016) How to recognize obsessive-compulsive disorder, Postgraduate Medicine, 10.1080/00325481.1991.11701039, 90:3, (131-143), Online publication date: 1-Sep-1991. Brewerton T (1991) Fluotexine-induced suicidality, serotonin, and seasonality, Biological Psychiatry, 10.1016/0006-3223(91)90173-J, 30:2, (190-196), Online publication date: 1-Jul-1991. Luescher U, McKeown D and Halip J (1991) Stereotypic or Obsessive-Compulsive Disorders in Dogs and Cats, Veterinary Clinics of North America: Small Animal Practice, 10.1016/S0195-5616(91)50041-3, 21:2, (401-413), Online publication date: 1-Mar-1991. Marder A (1991) Psychotropic Drugs and Behavioral Therapy, Veterinary Clinics of North America: Small Animal Practice, 10.1016/S0195-5616(91)50036-X, 21:2, (329-342), Online publication date: 1-Mar-1991. Fishbain D and Goldberg M (1991) Fluoxetine for Obsessive Fear of Loss of Control of Malodorous Flatulence, Psychosomatics, 10.1016/S0033-3182(91)72119-1, 32:1, (105-107), Online publication date: 1-Feb-1991. Hollander E, DeCaria C, Gully R, Nitescu A, Suckow R, Gorman J, Klein D and Liebowitz M (1991) Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder, Psychiatry Research, 10.1016/0165-1781(91)90113-4, 36:1, (1-17), Online publication date: 1-Jan-1991. Stanley M, Turner S and Borden J (1990) Schizotypal features in obsessive-compulsive disorder, Comprehensive Psychiatry, 10.1016/0010-440X(90)90065-Z, 31:6, (511-518), Online publication date: 1-Nov-1990. Zetin M (1990) Obsessive–compulsive disorder, Stress Medicine, 10.1002/smi.2460060410, 6:4, (311-321), Online publication date: 1-Oct-1990. Katz R, DeVeaugh-Geiss J and Landau P (1990) Clomipramine in obsessive-compulsive disorder, Biological Psychiatry, 10.1016/0006-3223(90)90408-T, 28:5, (401-414), Online publication date: 1-Sep-1990. Wilcox J (2012) Fluoxetine and Obsessive-Compulsive Disorder: A Naturalistic Study, Journal of Psychoactive Drugs, 10.1080/02791072.1990.10472560, 22:3, (355-356), Online publication date: 1-Jul-1990. Black D, Kelly M, Myers C and Noyes R (1990) Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls, Biological Psychiatry, 10.1016/0006-3223(90)90006-N, 27:3, (319-327), Online publication date: 1-Feb-1990. Jenike M (2009) The Pharmacological Treatment of Obsessive-Compulsive Disorders, International Review of Psychiatry, 10.3109/09540269009026610, 2:3-4, (411-425), Online publication date: 1-Jan-1990. Leonard H and Rapoport J (1989) Pharmacotherapy of Childhood Obsessive-Compulsive Disorder, Psychiatric Clinics of North America, 10.1016/S0193-953X(18)30407-6, 12:4, (963-970), Online publication date: 1-Dec-1989. Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download • 6 MB Published online2/01/89